Primary Central Nervous System Lymphoma - 27 Studies Found
| Recruiting |
: Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma : Lymphoma : 1999-11-01 :
|
| Completed |
: Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma : Lymphoma : 2000-09-11 :
|
| Withdrawn |
: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma : Lymphoma : 1999-11-01 :
|
| Completed |
: Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma : Lymphoma : 2003-12-10 :
|
| NOT_YET_RECRUITING |
: Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study : : 2025-08-02 : 1.8 Gy of 4-6 MV X-ray to a total dose of 23.4 Gy (13 fractions) will be delivered. |
| Completed |
: Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas : Primary Central Nervous System Lymphoma : 2025-08-02 : Participants will receive 900 mg/m^2 via IV infusion over 10 minutes every 3 weeks x 4-8 induction cycles (21 days per cycle) as part of the indu |
| COMPLETED |
: First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen) : Primary Central Nervous System Lymphoma : 2025-08-02 : The subjects received ORM regimen treatment every 21 days for a total of 6 cycles.The specific medication is as follows " Obutinib tablets |